TVM Life Science Innovation II SCSP
- Fund Information and Directors
| TVM Life Science Innovation II SCSP |
| Firm |
TVM Life Science Management Inc
|
| Fund # | 805-4015456079 |
| CIK # | 0001767198 |
| Sale | 2018-12-17
($368.9 M Offered, $368.9 M Sold)
|
| Fund | Venture Capital Fund |
| Phone | 3522461606152 |
| Address | 8, Rue Lou Hemmer
Senningerberg, Luxembourg L-1748 |
| Source |
[EDGAR]
[IAPD]
|
| Fund AUM and Sold ($M) |
|
|
| Fund Details |
| Director | TVM Life Science Innovation II GP S RL, TVM Life Science Innovation II GP Sa RL |
| Custodian | JP Morgan Securities LLC |
| Auditor | KPMG Luxembourg Societe Cooperative, KPMG Luxembourg Socit Cooprative |
| Marketer | OCP Capital LLC |
| Broker | JP Morgan Securities LLC |
| Jurisdiction | |
| Form D Offering |
| Filed | 2020-10-19 (D/A) |
| Exemption | 506(b), 3(c), 3(c)(7) |
| Minimum | $250,000 |
| Duration | One year or less |
| Commission | $15,383,006 |
| Finder's Fee | $475,000 |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
| TVM Life Science Ventures VIII GP SARL |
Executive Officer |
|
| TVM Life Science Innovation II GP SARL |
Executive Officer |
|
| TVM Life Science Management Inc |
Executive Officer |
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 212488016, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
316070668